Exact Sciences logo
United States
Choose your country

Select to view the solutions available in your location.

Select
Cancel
Login
Patient login

Track orders, get results, manage personal information, and more.

Provider login

Order tests, track orders, get results, and more.

December 15, 2022

Personalizing Breast Cancer Care: The Impact of Two Clinical Studies

At this year’s San Antonio Breast Cancer Symposium (SABCS), new data was presented from two long-term clinical studies: TAILORx and RxPONDER. Launched over a decade ago, both studies used the Oncotype DX Breast Recurrence Score® test to identify more precisely which breast cancer patients will truly benefit from chemotherapy.

These studies continue to be essential in providing patients and providers with the confidence to help make informed treatment decisions. To better understand how this data impacts breast cancer care, hear from Dr. Jennifer Racz, Director of U.S. Medical Affairs, Oncology at Exact Sciences as she elaborates on the latest findings.

DIVE DEEPER INTO Breast Cancer